Can pulsed Doppler technique measure changes in aortic blood flow in conscious rats?

PubWeight™: 1.74‹?› | Rank: Top 3%

🔗 View Article (PMID 2201207)

Published in Am J Physiol on August 01, 1990

Authors

S M Gardiner1, A M Compton, T Bennett, C J Hartley

Author Affiliations

1: Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, United Kingdom.

Articles citing this

Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol (1991) 1.90

Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats. Br J Pharmacol (1991) 1.40

Involvement of beta 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats. Br J Pharmacol (1992) 1.20

The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol (1991) 1.18

Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol (1991) 1.12

Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats. Br J Pharmacol (1994) 1.06

Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats. Br J Pharmacol (1991) 0.99

Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats. Br J Pharmacol (1991) 0.96

Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats. Br J Pharmacol (1991) 0.95

Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats. Br J Pharmacol (1993) 0.92

Lack of effect of TNF antibodies on the cardiovascular sequelae of lipopolysaccharide infusion in conscious rats. Br J Pharmacol (1995) 0.92

Regional and cardiac haemodynamic effects of NG, NG,dimethyl-L-arginine and their reversibility by vasodilators in conscious rats. Br J Pharmacol (1993) 0.91

Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats. Br J Pharmacol (1991) 0.88

Effects of chronic infusions of alpha-trinositol on regional and cardiac haemodynamics in conscious rats. Br J Pharmacol (1994) 0.87

Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol (1993) 0.87

Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats. Br J Pharmacol (1992) 0.84

Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174. Br J Pharmacol (1992) 0.83

Involvement of capsaicin-sensitive neurones in the haemodynamic effects of exogenous vasoactive peptides: studies in conscious, adult Long Evans rats treated neonatally with capsaicin. Br J Pharmacol (1992) 0.82

Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats. Br J Pharmacol (2000) 0.81

Effects of NG-nitro-L-arginine methyl ester on regional haemodynamic responses to MgSO4 in conscious rats. Br J Pharmacol (1994) 0.81

Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin. Br J Pharmacol (1991) 0.79

Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats. Br J Pharmacol (1993) 0.79

Tonic inhibitory control exerted by opioid peptides in the paraventricular nuclei of the hypothalamus on regional hemodynamic activity in rats. Br J Pharmacol (2002) 0.78

In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases. Front Pharmacol (2016) 0.77

Regional haemodynamic effects of mu-, delta-, and kappa-opioid agonists microinjected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats. Br J Pharmacol (1995) 0.77

Differential effects of captopril on regional haemodynamic responses to angiotensin I and bradykinin in conscious rats. Br J Pharmacol (1993) 0.75

Effect of ormeloxifene, a nonsteroidal once-a-week oral contraceptive, on systemic hemodynamics in adult female rats. J Pharmacol Pharmacother (2011) 0.75

Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats. Br J Pharmacol (1996) 0.75

Articles by these authors

Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest (2001) 7.20

Insurance-related differences in the risk of ruptured appendix. N Engl J Med (1994) 6.69

Myocardial ischemia and reperfusion: a murine model. Am J Physiol (1995) 3.38

Access to prenatal care following major Medicaid eligibility expansions. JAMA (1993) 3.04

Control of regional blood flow by endothelium-derived nitric oxide. Hypertension (1990) 2.93

Differences in hospital resource allocation among sick newborns according to insurance coverage. JAMA (1991) 2.59

Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol (1990) 2.58

Opioid users' attitudes towards and use of NHS clinics, general practitioners and private doctors. Br J Addict (1986) 2.18

Assessment of methods for estimating autonomic nervous control of the heart in patients with diabetes mellitus. Diabetes (1978) 2.04

An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun (1996) 1.99

Health service use among low-risk newborns after early discharge with and without nurse home visiting. J Am Board Fam Pract (1997) 1.97

Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol (1991) 1.90

Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats. Br J Pharmacol (1990) 1.80

Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester. Br J Pharmacol (1990) 1.77

Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol (1990) 1.72

Myocardial infarction and remodeling in mice: effect of reperfusion. Am J Physiol (1999) 1.62

Serial abuse in children who are shaken. Am J Dis Child (1990) 1.62

Regional hemodynamic effects of endothelin-1 in conscious, unrestrained, Wistar rats. J Cardiovasc Pharmacol (1989) 1.61

The effect of adrenaline upon cardiovascular and metabolic functions in man. Clin Sci (Lond) (1985) 1.58

An ultrastructural and histochemical study of the short-term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl. Br J Pharmacol (1970) 1.57

Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation (1985) 1.54

Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. Eur Heart J (2001) 1.53

Propofol and fentanyl compared with midazolam and fentanyl during third molar surgery. J Oral Maxillofac Surg (1998) 1.51

An ultrasonic pulsed Doppler system for measuring blood flow in small vessels. J Appl Physiol (1974) 1.50

The adrenergic nervous system of the domestic fowl (Gallus domesticus [L.]). Z Zellforsch Mikrosk Anat (1970) 1.45

Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J (1998) 1.44

An accurate, nontraumatic ultrasonic method to monitor myocardial wall thickening in patients undergoing cardiac surgery. J Am Coll Cardiol (1990) 1.44

Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats. Br J Pharmacol (1991) 1.40

Opposition to USDA inspections and the inclusion of rats, mice, and birds in the AWA. Contemp Top Lab Anim Sci (2001) 1.39

Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev (1992) 1.38

The use of gamma cameras to measure the disposition and fate of iodide in the rabbit [proceedings]. Br J Pharmacol (1978) 1.38

Interactions between neural mechanisms, the renin-angiotensin system and vasopressin in the maintenance of blood pressure during water deprivation: studies in Long Evans and Brattleboro rats. Clin Sci (Lond) (1985) 1.38

Monitoring of mixed venous oxygen saturation and pressure from biosensors in the right ventricle. A 24 hour study in patients with heart failure. Eur Heart J (1995) 1.37

The Saccharomyces cerevisiae RAD9 checkpoint reduces the DNA damage-associated stimulation of directed translocations. Mol Cell Biol (1998) 1.36

The Schizosaccharomyces pombe cwg2+ gene codes for the beta subunit of a geranylgeranyltransferase type I required for beta-glucan synthesis. EMBO J (1993) 1.35

Cardiovascular control in diabetes mellitus. Br Med J (1975) 1.34

Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol (1988) 1.32

Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation (1985) 1.31

Baroreflex sensitivity and responses to the Valsalva manoeuvre in subjects with diabetes mellitus. J Neurol Neurosurg Psychiatry (1976) 1.31

The involvement of noradrenergic nerves in the cardiovascular reflex responses to lower body negative pressure in the anaesthetised rabbit. Pflugers Arch (1976) 1.29

Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evans and Brattleboro rats. J Auton Nerv Syst (1988) 1.27

Cardiovascular reflex responses to apnoeic face immersion and mental stress in diabetic subjects. Cardiovasc Res (1976) 1.27

Successful isolation of a rat chromosome 1 blood pressure quantitative trait locus in reciprocal congenic strains. Hypertension (1998) 1.26

Antagonistic effect of human alpha-CGRP [8-37] on the in vivo regional haemodynamic actions of human alpha-CGRP. Biochem Biophys Res Commun (1990) 1.25

Diabetic autonomic neuropathy. Diabetes (1978) 1.25

A study of nexuses in visceral smooth muscle. J Cell Biol (1969) 1.25

Nerve-mediated excitation and inhibition of the smooth muscle cells of the avian gizzard. J Physiol (1969) 1.24

Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter. Am J Physiol (1985) 1.23

Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats. Life Sci (1991) 1.23

A search for the evidence supporting community paediatric practice. Arch Dis Child (1999) 1.22

Regional hemodynamic responses to adrenoceptor antagonism in conscious rats. Am J Physiol (1988) 1.22

Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci (2001) 1.21

The pulsed Doppler coronary artery catheter preliminary report of a new technique for measuring rapid changes in coronary artery flow velocity in man. Circulation (1977) 1.20

Involvement of beta 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats. Br J Pharmacol (1992) 1.20

Complex regional haemodynamic effects of anandamide in conscious rats. Br J Pharmacol (2002) 1.20

The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol (1991) 1.18

Studies on the avian gizzard: the development of the gizzard and its innervation. Z Zellforsch Mikrosk Anat (1969) 1.17

Attenuation of dysfunction in the postischemic 'stunned' myocardium by dimethylthiourea. Circulation (1987) 1.17

Saccharomyces cerevisiae rad51 mutants are defective in DNA damage-associated sister chromatid exchanges but exhibit increased rates of homology-directed translocations. Genetics (2001) 1.17

Expression of Saccharomyces cerevisiae MATa and MAT alpha enhances the HO endonuclease-stimulation of chromosomal rearrangements directed by his3 recombinational substrates. Mutat Res (1999) 1.16

NG-monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur J Pharmacol (1989) 1.16

Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats. Br J Pharmacol (1994) 1.16

Comparison of hepatic extraction of insulin and glucagon in conscious and anesthetized dogs. Endocrinology (1983) 1.16

Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol (1994) 1.15

Regional hemodynamic effects of calcitonin gene-related peptide. Am J Physiol (1989) 1.15

The age-associated alterations in late diastolic function in mice are improved by caloric restriction. J Gerontol A Biol Sci Med Sci (1997) 1.14

Synchronized pulsed Doppler blood flow and ultrasonic dimension measurement in conscious dogs. Ultrasound Med Biol (1978) 1.14

Biochemical and morphological correlates of acute experimental myocardial ischemia in the dog. IV. Energy mechanisms during very early ischemia. Circ Res (1979) 1.13

Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol (1991) 1.12

Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin. Br J Pharmacol (1990) 1.11

The influence of atropine and atenolol on the cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol (1992) 1.11

Post-exercise reduction of blood pressure in hypertensive men is not due to acute impairment of baroreflex function. Clin Sci (Lond) (1984) 1.11

Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br J Pharmacol (2001) 1.10

Cardiac baroreflex sensitivities in conscious, unrestrained, Long Evans and Brattleboro rats. J Auton Nerv Syst (1988) 1.10

Incidence of impact trauma with cranial injuries ascribed to shaking. Am J Dis Child (1990) 1.09

Subselective measurement of coronary blood flow velocity using a steerable Doppler catheter. J Am Coll Cardiol (1986) 1.08

Haemodynamic effects of the bacterial quorum sensing signal molecule, N-(3-oxododecanoyl)-L-homoserine lactone, in conscious, normal and endotoxaemic rats. Br J Pharmacol (2001) 1.07

Cardiovascular responses to lower body negative pressure in normal subjects and in patients with diabetes mellitus. Cardiovasc Res (1979) 1.07

Regulation of CD28 costimulation in human CD8+ T cells. J Immunol (1997) 1.06

Fluorescence histochemical and ultrastructural observations on the effects of intravenous injections of vinblastine on noradrenergic nerves. Z Zellforsch Mikrosk Anat (1973) 1.06

Hypoglycaemia, hypothermia and shivering in man. Clin Sci (Lond) (1981) 1.06

Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats. Br J Pharmacol (1994) 1.06

Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol (1995) 1.06